3-D Matrix Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 3-D Matrix Ltd with three other
companies in this sector in Japan:
BrightPath Biotherapeutics Co Ltd
sales of 529.61 million Japanese Yen [US$4.76 million]
of which 100%
was Commerical Physical Research),
DNA Chip Research, Inc.
(324.65 million Japanese Yen [US$2.92 million]
Human Metabolome Technologies Inc
(914.18 million Japanese Yen [US$8.22 million]
Sales increased substantially in 2017:
3-D Matrix Ltd reported sales of ¥615.85 million (US$5.54 million)
April of 2017.
increase of 334.2%
versus 2016, when the company's sales were ¥141.84 million.